Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that AZD3480 improves cognition in patients with
mild or moderate Alzheimer's disease, to assess the safety and tolerability of ZAD3480 and to
define the optimal dose(s) to be used in future trials.